Vimarsana
Biggest News Aggregation in the World

Page 11 - Jeff Borcherding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeff Borcherding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeff Borcherding Today - Breaking & Trending Today

Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Depart - Vimarsana News

Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Depart

LUND, Sweden, May 23, 2022 /PRNewswire/ -- The Pennsylvania and Maryland Departments of Health have granted...

Immunovia AB: Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray PanCan-d test available in 46 US states - Vimarsana News

Immunovia AB: Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray PanCan-d test available in 46 US states

LUND, Sweden, May 17, 2022 /PRNewswire/ -- The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), Clinical Laboratory

Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test ava - Vimarsana News

Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test ava

LUND, Sweden, May 17, 2022 /PRNewswire/ -- The Rhode Island Department of Health has granted Immunovia,...

Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US states - Vimarsana News

Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US states

/PRNewswire/ -- The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), Clinical...

Immunovia Cleared to Offer Pancreatic Cancer Test in Rhode Island - Vimarsana News

Immunovia Cleared to Offer Pancreatic Cancer Test in Rhode Island

The test is designed to detect nine serum biomarkers of pancreatic ductal adenocarcinoma, including the protein CA19-9.